Paul J. LimburgFollowAbbott (United States)2 papersORCID 0000-0002-2428-5675 ↗OpenAlex ↗PapersJournal of Medical EconomicsIn silico·2 OctEstimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspectiveJournal of HepatologyHuman trial·28 SepMulti-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study
Journal of Medical EconomicsIn silico·2 OctEstimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective
Journal of HepatologyHuman trial·28 SepMulti-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study